medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2023, Number 12

<< Back Next >>

Ginecol Obstet Mex 2023; 91 (12)

Pregnant hyperthyroidism, after SARS-CoV-2 infection. Case report

Vernaza-León NJ, Vargas-Victoria I, Abreu-Lomba A, Gómez-Gómez MC

Language: Spanish
References: 19
Page: 908-913
PDF size: 186.29 Kb.


ABSTRACT

Background: Hyperthyroidism associated with pregnancy has a variable incidence in different trimesters of pregnancy and puerperium. It predominates in the first trimester and at 7 to 9 months postpartum. It is mainly associated with Graves' disease and hyperemesis gravidarum due to human chorionic gonadotropin concentrations. Since the emergence of SARS-CoV-2 infection, the association between the two diseases has been documented.
Clinical case: 27-year-old primigravida with a maternal family history of hypothyroidism and a reported normal pregestational TSH (2.3 mIU/mL). Four weeks into her pregnancy, she had an uncomplicated SARS-CoV-2 infection with a positive diagnostic PCR test. Diagnosis and pharmacologic treatment were timely, and euthyroid status was achieved, allowing discontinuation of the medication and keeping the patient asymptomatic from an endocrine standpoint. At 36 weeks' gestation, she was diagnosed with severe pre-eclampsia, and it was decided to terminate the pregnancy by cesarean section, with a male newborn weighing 2550 g and 47 cm without complications. At postpartum follow-up, thyroid function remained euthyroid.
Conclusions: In the case patient, the association between COVID-19 in pregnancy and hyperthyroidism was evident. The case is of clinical interest because it allows the analysis of other causal factors of thyroid disease in pregnancy.


REFERENCES

  1. Kobaly K, Mandel SJ. Hyperthyroidism and Pregnancy.Endocrinol Metab Clin North Am 2019; 48 (3): 533-45.doi:10.1016/j.ecl.2019.05.002

  2. Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H,Dosiou C, et al. 2017 Guidelines of the American ThyroidAssociation for the Diagnosis and Management of ThyroidDisease During Pregnancy and the Postpartum. Thyroid2017; 27 (3): 315-89. doi:10.1089/thy.2016.0457

  3. Moleti M, Di Mauro M, Sturniolo G, Russo M, Vermiglio F.Hyperthyroidism in the pregnant woman: Maternal andfetal aspects. JJ Clinical & Translational Endocrinology 2019;16: 100190. https://doi.org/10.1016/j.jcte.2019.100190

  4. Dotan A, Muller S, Kanduc D, David P, Halpert G, ShoenfeldY. The SARS-CoV-2 as an instrumental trigger of autoimmunity.Autoimmunity Reviews 2021; 20: 102792. https://doi.org/10.1016/j.autrev.2021.102792

  5. Caron P. Thyroid disorders and SARS-CoV-2 infection: Frompathophysiological mechanism to patient management.Ann Endocrinol 2020; 81 (5): 507-10. doi:10.1016/j.ando.2020.09.001

  6. Wang Y, Wang Y, Luo W, Huang L, Xiao J, Li F. A comprehensiveinvestigation of the mRNA and protein level of ACE2,the putative receptor of SARS-CoV-2, in human tissues andblood cells. Int J Medical Sciences 2020; 17 (11): 1522-31.doi:10.7150/ijms.46695

  7. Murugan AK, Alzahrani AS. SARS-CoV-2 plays a pivotal rolein inducing hyperthyroidism of Graves’ disease. Endocrine2021; 73 (2): 243-54. https://doi.org/10.1007/s12020-021-02770-6

  8. Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, LatrofaF. Subacute Thyroiditis after SARS-CoV-2 infection. J ClinEndocrinol Metab 2020; 105 (7): 2367-70. doi:10.1210/clinem/dgaa276

  9. López-Frías M, Perdomo CM, Galofré JC, Tiroiditis subagudatras infección por COVID-19. Rev Clín Esp 2021; 221 (6):370-72. https://doi.org/10.1016/j.rce.2021.01.002

  10. Andersen SL, Olsen J, Carlé A, Laurberg P. Hyperthyroidismincidence fluctuates widely in and around pregnancyand is at variance with some other autoimmune diseases:a Danish population-based study. J Clin EndocrinolMetab 2015; 100 (3): 1164-71. https://doi.org/10.1210/jc.2014-3588

  11. Doubleday AR, Sippel RS. Hyperthyroidism. GlandSurg 2020; 9 (1): 124-35. https://doi.org/10.21037/gs.2019.11.01

  12. Singh S, Sandhu S. Thyroid disease and pregnancy. Stat-Pearls Treasure Island: StatPearls Publishing, 2023. https://www.ncbi.nlm.nih.gov/books/NBK538485/

  13. Shi Q, Wu M, Chen P, Wei B, Tan H, Huang P, Et al. Criminalof adverse pregnant outcomes: a perspective fromthyroid hormone disturbance caused by SARS-CoV-2.Front Cell Infect Microbiol 2022; 11: 791654. doi: 10.3389/fcimb.2021.791654

  14. Chen W, Tian Y, Li Z, Zhu J, Wei T, Lei J. Potential interactionbetween SARS-CoV-2 and Thyroid: a review. Endocrinology2021; 162 (3): bqab004. doi:10.1210/endocr/bqab004

  15. Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M,et al. Outcome of coronavirus spectrum infections (SARS,MERS, COVID-19) during pregnancy: a systematic reviewand meta-analysis. AJOG MFM 2020; 2 (2): 100107. https://doi.org/10.1016/j.ajogmf.2020.100107

  16. Conde-Agudelo A, Romero R. SARS-CoV-2 infection duringpregnancy and risk of preeclampsia: a systematic reviewand meta-analysis. AJOG MFM 2021; 226 (1): 68-89.e3.https://doi.org/10.1016/j.ajog.2021.07.009

  17. Moore LE. Thyroid disease in pregnancy: A review ofdiagnosis, complications and management. World J ObstetGynecol 2016; 5 (1): 66-72. http://dx.doi. org/10.5317/wjog.v5.i1.66

  18. Momotani N, Noh JY, Ishikawa N, Ito K. Effects of propylthiouraciland methimazole on fetal thyroid status inmothers with Graves’ hyperthyroidism. JCE & M 1997; 82(11): 3633-36. https://doi.org/10.1210/jcem.82.11.4347

  19. Dumitrascu MC, Nenciu AE, Florica S, Nenciu CG, PetcaA, Petca RC, et al. Hyperthyroidism management duringpregnancy and lactation (Review). Exp Ther Med 2021; 22(3): 960. doi: 10.3892/etm.2021.10392




2020     |     www.medigraphic.com